| Literature DB >> 18467330 |
Minying Zhang1, Xuefeng Wu, Andrew J Lee, Wei Jin, Mikyoung Chang, Ato Wright, Tadaatsu Imaizumi, Shao-Cong Sun.
Abstract
The IkappaB kinase (IKK)-related kinases, IKKepsilon and TBK1, participate in the induction of type I interferons (IFNs) during viral infections. Deregulated activation of IKKepsilon and TBK1 also contributes to the abnormal cell survival and transformation. However, how these kinases are negatively regulated remains unclear. We show here that the tumor suppressor CYLD has an essential role in preventing aberrant activation of IKKepsilon/TBK1. CYLD deficiency causes constitutive activation of IKKepsilon/TBK1, which is associated with hyper-induction of IFNs in virus-infected cells. We further show that CYLD targets a cytoplasmic RNA sensor, RIG-I, and inhibits the ubiquitination of this IKKepsilon/TBK1 stimulator. Consistent with the requirement of ubiquitination in RIG-I function, CYLD potently inhibits RIG-I-mediated activation of the IFN-beta promoter. These findings establish CYLD as a key negative regulator of IKKepsilon/TBK1 and suggest a role for CYLD in the control of RIG-I ubiquitination.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18467330 PMCID: PMC2441564 DOI: 10.1074/jbc.M801451200
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157